Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Tim Jones will lead Grey’s pharma business as CCO.
Within the next few weeks, the effort will have expanded to include around 40,000 pharmacies.
Lisa Stockman-Mauriello’s desperate plea for compassionate access to an experimental ALS drug was rebuffed by Biogen this week.
Marketers adjust to the pharmacist’s expanded role in the COVID-19 era.
Three drug store giants pitched in on a PSA effort aimed at upping public confidence in COVID-19 vaccination.
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
Drug companies kicked off the new year by announcing price hikes.
Allergan’s campaign for Vraylar portrays the highs and lows of bipolar disorder exactly as patients describe them.
The new company will sell both Mylan’s branded and generic drugs and Pfizer’s off-patent treatments, such as Viagra.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.